Home
About Us
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
Archive
My bio page
Edit user profile
Signature
Reset the password
Home
About Us
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
Archive
A peer-reviewed protocol journal. No publication fee; no access fee.
Search
Overview
Published
Edited
Reviewed
Following
Feedback
Q&A
Samuel Bernal
1 protocol
View all coauthors >
Marvin Ilacas De los Santos
Senior Research Scientist, Globetek Science Foundation
Research focus
Immunology
Cancer Biology
Biological Therapeutics
Cellular Therapy
Immune Engineering
T cell biology
Molecular Immunology
Autoimmune Disease
Immunotherapy
Contributions
1
Author merit
Reviewer merit
Editor merit
Lab information
https://globetekscientific.wixsite.com/home
Publications
http://systems.enpress-publisher.com/index.php/ti/article/view/1064/826
CAR-T Therapy for Solid Tumors: Development of New Strategies (Trends in Immunotherapy)
1 Protocol published
Cellular Retention Assay to Determine the Interaction Frequency of CD19-directed Chimeric Antigen Receptor (CAR) Engineered Cells against CD19
+
Leukemic Cells
Authors:
Marvin I. De los Santos
and
Samuel D. Bernal
,
date:
09/05/2019,
view:
2049,
Q&A:
0
Cancer recognition by chimeric antigen receptor T (CAR-T) cell is prerequisite for cancer killing to occur. Anomalies in the binding specificity of scFv in the CAR construct may prevent successful eradication of these cancer cells. In some cases, ...
More >
following
More protocols >
0 Protocol feedback
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.